Vertex Pharmaceuticals Inc has gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been linked to hundreds of thousands of deaths.
Vertex’s pill, called Journavx, received US Food and Drug Administration clearance to treat moderate to severe acute pain, a statement said on Thursday. The wholesale acquisition cost for the twice-daily medicine is set at US$15.50 per 50 milligram tablet, Vertex said.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, surgeries, and other injuries and procedures. More than half a million US deaths were linked to overdoses of the addictive drugs from 1999 to 2019, official figures show, with more than 70,000 in the year through June last year alone.
Photo:AP
While some fatalities involved use of illicit drugs, many people begin taking them after they lost access to prescribed opioids, leading doctors and health officials to look for other options.
Vertex’s drug has been hailed as a scientific breakthrough, because it allays pain without entering the brain, minimizing the risk of addiction and dependence that can lead patients to ramp up doses to dangerous levels. It is a key to Vertex’s strategy of diversifying beyond its core business centered on cystic fibrosis treatments.
While some analysts predict the painkiller would become a multibillion-dollar product for a company needing a growth driver, questions remain about its price and commercial potential. Health insurers and hospitals might continue steering patients to opioids, which — while dangerous — are cheap and effective.
Vertex has been pressing Congress to create policies that would help its product succeed. For example, the No Pain Act, which provides extra Medicare reimbursement to hospitals that prescribe alternatives to opioids, went into effect this year.
The company plans to focus on selling its drug to the about 2,000 US hospitals that see about two-thirds of patients in acute pain, chief operating officer Stuart Arbuckle said.
Boston-based Vertex, the maker of cystic fibrosis treatments like the blockbuster Trikafta, has worked for more than two decades to develop a nonaddictive pain drug. Journavx, also called suzetrigine, blocks a structure in the nerve cells that send pain signals to the brain.
In late-stage studies of patients with acute pain after surgery, Vertex’s drug worked better than a placebo, but failed to reduce pain faster than a combination of acetaminophen, better known as Tylenol, and an opioid. That could present a challenge for Vertex, as new drugs typically must outperform what is already on the market to gain traction.
Vertex is studying the same pill to treat chronic pain lasting at least three months, which affects about 50 million Americans. The company encountered a setback in December when a mid-stage trial showed the drug failed to work better than a placebo in lower back pain, causing the shares to plunge.
The Burmese junta has said that detained former leader Aung San Suu Kyi is “in good health,” a day after her son said he has received little information about the 80-year-old’s condition and fears she could die without him knowing. In an interview in Tokyo earlier this week, Kim Aris said he had not heard from his mother in years and believes she is being held incommunicado in the capital, Naypyidaw. Aung San Suu Kyi, a Nobel Peace Prize laureate, was detained after a 2021 military coup that ousted her elected civilian government and sparked a civil war. She is serving a
REVENGE: Trump said he had the support of the Syrian government for the strikes, which took place in response to an Islamic State attack on US soldiers last week The US launched large-scale airstrikes on more than 70 targets across Syria, the Pentagon said on Friday, fulfilling US President Donald Trump’s vow to strike back after the killing of two US soldiers. “This is not the beginning of a war — it is a declaration of vengeance,” US Secretary of Defense Pete Hegseth wrote on social media. “Today, we hunted and we killed our enemies. Lots of them. And we will continue.” The US Central Command said that fighter jets, attack helicopters and artillery targeted ISIS infrastructure and weapon sites. “All terrorists who are evil enough to attack Americans are hereby warned
Seven wild Asiatic elephants were killed and a calf was injured when a high-speed passenger train collided with a herd crossing the tracks in India’s northeastern state of Assam early yesterday, local authorities said. The train driver spotted the herd of about 100 elephants and used the emergency brakes, but the train still hit some of the animals, Indian Railways spokesman Kapinjal Kishore Sharma told reporters. Five train coaches and the engine derailed following the impact, but there were no human casualties, Sharma said. Veterinarians carried out autopsies on the dead elephants, which were to be buried later in the day. The accident site
‘NO AMNESTY’: Tens of thousands of people joined the rally against a bill that would slash the former president’s prison term; President Lula has said he would veto the bill Tens of thousands of Brazilians on Sunday demonstrated against a bill that advanced in Congress this week that would reduce the time former president Jair Bolsonaro spends behind bars following his sentence of more than 27 years for attempting a coup. Protests took place in the capital, Brasilia, and in other major cities across the nation, including Sao Paulo, Florianopolis, Salvador and Recife. On Copacabana’s boardwalk in Rio de Janeiro, crowds composed of left-wing voters chanted “No amnesty” and “Out with Hugo Motta,” a reference to the speaker of the lower house, which approved the bill on Wednesday last week. It is
RSS